Several prominent financial institutions have recently made changes to their positions in
Zoetis Inc. (NYSE:ZTS), involving selling, buying, and adjusting the number of holdings. Most noticeably,
Corebridge Financial Inc.,
MetLife Investment Management,
Kestra Advisory Services LLC, and
Comerica Bank have sold their shares, while
Soros Capital Management,
Harvest Portfolios Group, and
Epoch Investment Partners among others have increased their respective ownership. Zoetis has also announced a participation in the
Morgan Stanley 23rd Annual Global Healthcare Conference and secured a new
$1.25 billion credit facility. The stock price has been resilient despite the low volume ranking, and analysts have issued a negative estimate for Zoetis' earnings. In contrast, Zoetis'
growth prospects are continually being highlighted by market analysts, especially after a better-than-expected sales performance for Q2. Zoetis has also broadened its underwriter base with a
$1.85 billion debt offering.
Zoetis ZTS News Analytics from Tue, 06 May 2025 07:00:00 GMT to Sat, 30 Aug 2025 23:32:11 GMT -
Rating 4
- Innovation 2
- Information 5
- Rumor -6
